Patent foramen ovale closure by using transesophageal echocardiography for cryptogenic stroke: single center experience in 132 consecutive patients

被引:12
作者
Han, Yangyang [1 ]
Zhang, Xiquan [2 ]
Zhang, Fengwei [1 ]
机构
[1] Shandong Univ, Affiliated Hosp, Dept Cardiovasc Surg, Linyi Peoples Hosp, Jiefang St 27, Linyi 276000, Shandong, Peoples R China
[2] Shandong Univ, Dept Cardiovasc Surg, Qilu Hosp, West Wenhua Rd 107, Jinan 250012, Shandong, Peoples R China
关键词
Patent foramen ovale; Percutaneous closure; Occluder; Cryptogenic stroke; Migraine; Echocardiography; Transesophageal; ATRIAL SEPTAL-DEFECTS; TRANSCATHETER CLOSURE; PERCUTANEOUS CLOSURE; DEVICE CLOSURE; MIGRAINE; METAANALYSIS; FLUOROSCOPY; OUTCOMES; IMPACT;
D O I
10.1186/s13019-020-1042-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Percutaneous closure of patent foramen ovale (PFO) is routinely performed using plain fluoroscopy in the catheter room. This method results in inevitable radiation damage, adverse effects of contrast agents on kidneys, and high cost. We performed PFO closure with a simplified and economical transesophageal echocardiography (TEE)-only guided approach in the operating room. This study aimed to investigate the feasibility, safety, and effectiveness of the percutaneous closure of PFO by only using TEE. Methods We reviewed the medical records of patients who underwent percutaneous PFO closure at our center from December 2013 to December 2017. A total of 132 patients with PFO and cryptogenic strokes underwent PFO closure by using cardi-O-fix PFO device under TEE guidance. The participants comprised 64 and 68 male and female patients, respectively. The mean age and body weight of the patients were 39.40 +/- 13.22 years old (12-68 years old) and 65.42 +/- 9.70 kg (40-95 kg), respectively. All patients only received aspirin (3-5 mg/kg body weight, oral administration) for 6 months. Contrast-enhanced transthoracic echocardiography (c-TTE) with Valsalva maneuver was performed during follow-up, and questionnaire surveys were obtained at 3, 6, and 12 months after the procedure. Results All (100%) patients were successfully closed. Follow-ups were conducted for 13 months to 48 months, with an average of 27 months. No severe complications were found during the follow-up period. Paroxysmal atrial fibrillation occurred in 4 patients within 3 months after the procedure. No recurrent stroke or death occurred in all patients during the follow-up period. Transient ischemic attack occurred in one patient 6 months after the procedure. Ten (7.6%) patients had a right-to-left shunt, as demonstrated by c-TTE at 12 months of follow-up. Among the 57 patients suffering from migraine, significant relief or resolution was reported by 42 (73.7%) patients. Conclusion TEE-only guided PFO closure was a safe, feasible, and effective method that did not require the use of X-rays and contrast agents.
引用
收藏
页数:8
相关论文
共 24 条
[1]   Patent foramen ovale closure vs. medical therapy for cryptogenic stroke: ameta-analysis of randomized controlled trials [J].
Ahmad, Yousif ;
Howard, James P. ;
Arnold, Ahran ;
Shin, Matthew Shun ;
Cook, Christopher ;
Petraco, Ricardo ;
Demir, Ozan ;
Williams, Luke ;
Iglesias, Juan F. ;
Sutaria, Nilesh ;
Malik, Iqbal ;
Davies, Justin ;
Mayet, Jamil ;
Francis, Darrel ;
Sen, Sayan .
EUROPEAN HEART JOURNAL, 2018, 39 (18) :1638-1649
[2]  
Branch of cardiovascular physicians of Chinese physicians association, 2015, CHINESE HEART J, V27, P373
[3]   Percutaneous versus surgical closure of secundum atrial septal defects: a systematic review and meta-analysis of currently available clinical evidence [J].
Butera, Gianfranco ;
Biondi-Zoccai, Giuseppe ;
Sangiorgi, Giuseppe ;
Abella, Raul ;
Giamberti, Alessandro ;
Bussadori, Claudio ;
Sheiban, Imad ;
Saliba, Zackhia ;
Santoro, Tiberio ;
Pelissero, Gabriele ;
Carminati, Mario ;
Frigiola, Alessandro .
EUROINTERVENTION, 2011, 7 (03) :377-385
[4]   Closure of Patent Foramen Ovale and Cryptogenic Stroke: Unresolved Issues [J].
Diener, Hans-Christoph ;
Gerloff, Christian ;
Thaler, David E. ;
Woehrle, Jochen .
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2018, 18 (12)
[5]   To Be or Not to Be Patent: The Relationship Between Migraine and Patent Foramen Ovale [J].
Eren, Nihan Kahya ;
Bulbul, Nazli G. ;
Tuluce, Selcen Yakar ;
Nazli, Cem ;
Beckmann, Yesim .
HEADACHE, 2015, 55 (07) :934-942
[6]   Off-pump occlusion of trans-thoracic minimal invasive surgery (OPOTTMIS) on simple congenital heart diseases (ASD, VSD and PDA) attached consecutive 210 cases report: A single institute experience [J].
Guo, Qing-kui ;
Lu, Zhi-qian ;
Cheng, Shao-fei ;
Cao, Yong ;
Zhao, Yong-hong ;
Zhang, Cheng ;
Zhang, Yue-li .
JOURNAL OF CARDIOTHORACIC SURGERY, 2011, 6
[7]   A six-item short-form survey for measuring headache impact:: The HIT-6™ [J].
Kosinski, M ;
Bayliss, MS ;
Bjorner, JB ;
Ware, JE ;
Garber, WH ;
Batenhorst, A ;
Cady, R ;
Dahlöf, CGH ;
Dowson, A ;
Tepper, S .
QUALITY OF LIFE RESEARCH, 2003, 12 (08) :963-974
[8]   Peratrial Device Closure of Perimembranous Ventricular Septal Defects Through a Right Parasternal Approach [J].
Li Hongxin ;
Zhang, Nan ;
Guo Wenbin ;
Zhang, Wen-Long ;
Wang, Zheng-Jun ;
Liang, Fei ;
Zou, Cheng-Wei .
ANNALS OF THORACIC SURGERY, 2014, 98 (02) :668-674
[9]   Feasibility and effectiveness of percutaneous balloon mitral valvuloplasty under echocardiographic guidance only [J].
Liu, Yao ;
Guo, Gai-Li ;
Wen, Bin ;
Wang, Shouzheng ;
Ou-Yang, Wen-Bin ;
Xie, Yongquan ;
Pan, Xiang-Bin .
ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES, 2018, 35 (10) :1507-1511
[10]   Simplified percutaneous closure of patent foramen ovale and atrial septal defect with use of plain fluoroscopy: Single operator experience in 110 consecutive patients [J].
Manolis, Antonis S. ;
Koulouris, Spyridon ;
Rouska, Efthymia ;
Pyrros, John .
INDIAN HEART JOURNAL, 2018, 70 (01) :24-31